We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The patent dispute over Janssen’s Remicade continues to balloon, with the drugmaker suing GE Healthcare subsidiary HyClone Laboratories over the use of cell cultures to grow a biosimilar of the drug. Read More
The House and Senate conferees met Wednesday to mark up the Comprehensive Addiction and Recovery Act, making a few changes but leaving intact two critical elements related to opioid approval and FDA oversight. Read More